UCB Uses AI With Cradle to Design New Antibodies
UCB, a drugmaker, has partnered with Cradle to design its antibodies using artificial intelligence. The deal shows AI being used to speed up how antibody-based medicines are created. The partnership is a sign of growing AI use in drug research.
Quick glossaryUCB, antibody
- UCB
- A Belgium-based drugmaker known for medicines that treat immune and nerve-related diseases.
- antibody
- A protein the immune system makes to spot and lock onto germs or harmful cells, and which medicines can also be built from.
Burning Potato score: 74%